As of Jul 31
| +0.28 / +1.33%|
The 2 analysts offering 12-month price forecasts for Osiris Therapeutics Inc have a median target of 23.50, with a high estimate of 28.00 and a low estimate of 19.00. The median estimate represents a +10.17% increase from the last price of 21.33.
The current consensus among 2 polled investment analysts is to Buy stock in Osiris Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.